Semper Paratus Acquisition Corp.

02/21/2024 | Press release | Distributed by Public on 02/21/2024 15:55

Code of Ethics - Form 8-K

Item 5.05 Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics.

On February 14, 2024, Tevogen Bio Holdings Inc. (the "Company") adopted a Code of Business Conduct and Ethics (the "Code") applicable to all officers, directors, and employees of the Company, including its Chief Executive Officer, Chief Financial Officer, and other executive officers. The Code is designed to deter wrongdoing and to promote honest and ethical conduct, full, fair, accurate, timely, and understandable disclosure in the Company's public communications, compliance with applicable laws, rules, and regulations, protection of Company assets, prompt internal reporting of Code violations, and accountability for adherence to the Code. The foregoing description of the Code is qualified in its entirety by reference to the text of the Code, a copy of which is filed as Exhibit 14.1 to this report and incorporated herein by reference.